Dendreon selected Ennov Regulatory Suite to implement a cloud-based, unified electronic document management, publishing, and regulatory information management (RIM) software system to manage regulatory documents, publishing and product registrations, as well as lifecycles. Dendreon chose the Ennov software for its intuitive user experience and truly unified platform that meets Dendreon’s functional requirements.
“We are very honored to be selected by Dendreon and we welcome them to the growing community of Ennov Regulatory customers. We are looking forward to working with them and are committed to helping them achieve their Regulatory milestones.”Olivier Pâris, President and CEO of Ennov
To learn more about Ennov’s innovative regulatory suite, visit www.ennov.com.
Ennov provides the most intuitive, comprehensive, and cost-effective suite of software solutions for the life sciences industry. From leading pharmaceutical companies to emerging biotechnology companies, we proudly serve over 250 companies and 250,000 users around the world. Our solutions are designed and built to support the entire Life Sciences R&D continuum including Clinical, Regulatory, Quality, Pharmacovigilance and Commercial. Ennov is headquartered in Paris and has offices in the US, UK and Vietnam.
Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cell therapy market. Dendreon’s flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells and has been prescribed to over 40,000 patients in the U.S. since 2010. Dendreon is headquartered in Seal Beach, California. For more information, please visit www.dendreon.com.